Implementing single-cell cloning by limiting dilution in CRISPR-edited lymphoblastoid cell lines (LCLs) presents challenges and considerations, including variations in CRISPR editing efficiency, cell viability, genetic heterogeneity, selection strategies, and clone validation. While specific literature on this topic might be limited, similar techniques have been successful in other cell types. Successful implementation requires optimizing CRISPR editing protocols for LCLs, thorough validation of clones, and consultation with experts in CRISPR editing and cell biology.